Finished product reference

Pediatric Grippe

Syrup · Oral · 0.67 mg/10 mg/5mL · 120 mL

List code
21610
Pharmacologic class
Paediatric cold and influenza symptomatic combination (category of products)

What it is and how it works

This is a category of fixed-combination syrups for symptomatic relief of colds and flu in children, typically combining an analgesic-antipyretic (e.g. paracetamol) with an antihistamine (e.g. chlorphenamine) and/or a decongestant (e.g. pseudoephedrine or phenylephrine), each acting on a different symptom. They do not treat the underlying viral infection.

Indications

Short-term symptomatic relief of fever, nasal congestion, rhinorrhoea, sneezing and aches associated with common cold and influenza in children.

Contraindications

Varies with the components; generally hypersensitivity, and decongestant- or antihistamine-containing products in young children (many regulators advise against cough and cold combination products in children under 6 years), concurrent MAOI use and severe hepatic impairment for paracetamol-containing products.

Warnings and precautions

Risk of accidental paracetamol overdose if given with other paracetamol-containing medicines; check total daily dose. Sedating antihistamines and decongestants may cause drowsiness, paradoxical excitation, tachycardia or seizures in young children. Use the dosing device provided and for no longer than a few days without medical advice.

Storage and supply

Store below 25 °C, protected from light; keep out of the reach of children.

Source: reference summary prepared from the EU SmPC/EPAR, BNF and WHO Model Formulary. The approved product information in Iran governs.

Other presentations of the same active ingredient

Reference information for professional sourcing and registration enquiries, not medical advice or a promotion. Drug information is condensed from US FDA prescribing information (public domain, via openFDA and DailyMed) and does not replace the product’s approved labelling in Iran. Availability, origin and documentation are confirmed per enquiry.

Tell us the quantity, the market and the timing.

Send the molecule or ingredient, the specification and the destination. We reply from Tehran with the questions, the documents and the next step.

Telephone+98 21 8888 3325 · office hours 09:00–17:00, Tehran
OfficeHaniya Parsan Darou, 3rd floor, No. 326, Zafar Street, Africa Boulevard, Tehran 1968734974, Iran
Emailcontact@hanpars.com